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Attitudes Toward Prohibiting Tobacco
Sales in Pharmacy Stores Among
U.S. Adults
Teresa W. Wang, PhD, MS,1,2 Israel T. Agaku, DMD, MPH,1 Kristy L. Marynak, MPP,1
Brian A. King, PhD, MPH1
Introduction: Pharmacy stores are positioned to cultivate health and wellness among patrons. This
study assessed attitudes toward prohibiting tobacco product sales in pharmacy stores among U.S.
adults.
Methods: Data from the 2014 Summer Styles, an Internet survey of U.S. adults aged Z18 years
(n¼4,269), were analyzed in 2015. Respondents were asked: Do you favor or oppose banning the sale
of all tobacco products in retail pharmacy stores? Responses were: strongly favor, somewhat favor,
somewhat oppose, and strongly oppose. Prevalence ratios were calculated using multivariate Poisson
regression to determine sociodemographic correlates of favorability (strongly or somewhat).
Results: Among all adults, 66.1% “strongly” or “somewhat” favored prohibiting tobacco product
sales in pharmacy stores. Favorability was 46.5% among current cigarette smokers, 66.3% among
former smokers, and 71.8% among never smokers. Favorability was 47.8% among current non-
cigarette tobacco users, 63.2% among former users, and 71.4% among never users. Following
adjustment, favorability was more likely among women compared with men (po0.05). Conversely,
favorability was less likely among the following: adults aged 25–44 years and 45–64 years compared
with those agedZ65 years, those with annual household income of $15,000–$24,999 compared with
Z$60,000, current cigarette smokers compared with never smokers, and current and former non-
cigarette tobacco users compared with never tobacco users (po0.05).
Conclusions: Most U.S. adults favor prohibiting tobacco sales in retail pharmacy stores.
Eliminating tobacco product sales in these settings may reinforce pharmacy stores’ efforts to
promote wellness, and further cultivate social climates that reduce the desirability, acceptability, and
accessibility of tobacco.
(Am J Prev Med 2016;51(6):1038–1043) Published by Elsevier Inc. on behalf of American Journal of Preventive
Medicine
Introduction
Pharmacy stores are positioned to cultivate healthand wellness among patrons. However, many U.S.pharmacies sell and advertise tobacco, the nation’s
leading preventable cause of death and disease.1 This is an
established concern among pharmacists, whose professio-
nal obligation is to promote their patients’ health.2–4
Just as pharmacists’ attitudes can shape tobacco-free
practices,5 public attitudes toward tobacco control inter-
ventions can inform policy development, implementa-
tion, and sustainment. Previous studies have documented
general public favorability toward tobacco-related sales
restrictions in pharmacy stores at national and local
levels, and variations in favorability by sociodemographic
characteristics and cigarette smoking status.6,7 However,
increasingly more communities across the U.S. have
since implemented policies that prohibit the sale of
tobacco products in these settings.8 Moreover, the
tobacco product landscape continues to diversify, and
no study has assessed variations in public attitudes
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toward such policies by other forms of tobacco product
use beyond cigarettes. Accordingly, this study assessed
the prevalence and determinants of favorability toward
prohibiting the sale of tobacco products in pharmacy
stores among a nationally representative sample of U.S.
adults in 2014.
Methods
Data Source
Data came from Summer Styles, a web-based survey conducted by
Porter Novelli to explore health behaviors and attitudes among
U.S. adults aged Z18 years. Styles respondents are drawn from
the nationally representative KnowledgePanels, which uses
probability-based sampling to recruit online panelists regardless
of landline phone or Internet access. As described previously,
Summer Styles is sent to a stratified random sample of respond-
ents, and data are weighted to be nationally representative using
Current Population Survey distributions.9 In 2014 (JuneJuly),
4,269 respondents completed Summer Styles, yielding a 69%
response rate. This secondary analysis of de-identified data was
exempt from human subjects review.
Measures
Participants were asked: Do you favor or oppose banning the sale of
all tobacco products in retail pharmacy stores? Adults who
responded strongly favor or somewhat favor were considered to
favor a policy prohibiting all tobacco sales in pharmacy stores.
Favorability was assessed by cigarette smoking status, non-
cigarette tobacco product use (i.e., cigars or big cigars; cigarillos;
little cigars; chewing tobacco, snuff, or dip; electronic cigarettes or
e-cigarettes; electronic hookahs, hookah pens, or vape pens; some
other electronic vapor product such as electronic cigars or
electronic pipes; water pipes; roll-your-own cigarettes; flavored
cigars; snus; dissolvable tobacco), and sociodemographics (sex,
age, race/ethnicity, education, annual household income, and U.S.
region).
Statistical Analysis
Point estimates and 95% CIs were calculated overall and by
sociodemographics, cigarette smoking status, and non-cigarette
tobacco product use. Multivariate Poisson regression was used to
calculate adjusted prevalence ratios (APRs) of the association
between favorability and sociodemographics, cigarette smoking,
and non-cigarette tobacco use. Analyses were conducted in 2015
using R, version 3.2.2.
Results
Overall, 66.1% of U.S. adults favored (“strongly” or
“somewhat”) prohibiting tobacco product sales in phar-
macy stores; 20.1% “somewhat opposed” and 13.8%
“strongly opposed” the idea (Table 1). Prevalence of
favorability was 62.2% among men and 69.7% among
women. Favorability ranged from 63.7% among adults
aged 25–44 years to 72.2% among adults agedZ65 years;
from 64.6% among non-Hispanic blacks to 70.4% among
non-Hispanic other races; from 61.7% among adults with
less than a high school education to 70.1% among those
with a college degree; from 48.0% among adults with
annual household income o$15,000 to 69.0% among
adults with income Z$60,000; and from 63.9% in the
South to 70.2% in the West. Favorability was 46.5%
among current cigarette smokers, 66.3% among former
smokers, and 71.8% among never smokers. Favorability
was 47.8% among current non-cigarette tobacco users,
63.2% among former non-cigarette tobacco users, and
71.4% among never non-cigarette tobacco users.
The adjusted likelihood of favorability was greater
among women than men (APR¼1.08, 95% CI¼1.03,
1.14) (Table 2). The likelihood of favorability was lower
among those aged 25–44 years (APR¼0.91, 95%
CI¼0.86, 0.98) and 45–64 years (APR¼0.94, 95%
CI¼0.88, 0.99) than those agedZ65 years; among those
with annual household income o$15,000 (APR¼0.82,
95% CI¼0.71, 0.94) than those with income Z$60,000;
among current cigarette smokers (APR¼0.73, 95%
CI¼0.65, 0.82) than never smokers; and among current
(APR¼0.80, 95% CI¼0.70, 0.92) or former (APR¼0.93,
95% CI¼0.87, 0.99) non-cigarette tobacco users than
never users.
Discussion
This study reveals that two thirds of U.S. adults, includ-
ing nearly half of cigarette smokers and non-cigarette
tobacco users, favor prohibiting the sale of tobacco
products in retail pharmacy stores. A majority of all
assessed sociodemographic groups favored prohibiting
tobacco sales in pharmacies, but the likelihood of
favoring such a policy was lower among adults aged
25–44 years and 45–64 years, and among adults with
annual income o$15,000. These findings are generally
consistent with previous surveys, which indicate cigarette
smokers are less likely to have favorable attitudes toward
tobacco-related sales restrictions in pharmacies.6,7 How-
ever, this study is the first to document that current users
of non-cigarette tobacco products are also less likely to
demonstrate favorability for such policies than never
users. Non-cigarette tobacco product users are an
important subgroup to consider, as tobacco-free phar-
macy policies typically address the diversity of tobacco
products available on the market.10
The sale of tobacco products in retail pharmacies has
the potential to undermine the promotion of patient
health, especially among combustible tobacco users.
More than 16 million Americans currently live with
a smoking-related illness,1 and cigarette smoking
can complicate chronic disease management and
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Table 1. Favorability Toward Prohibiting Tobacco Product Sales in Retail Pharmacy Stores Among U.S. Adults, 2014a
% (95% CI)
Characteristic n (%) Strongly favor Somewhat favor Somewhat oppose Strongly oppose
Overall 4,198 42.3 (40.5, 44.1) 23.8 (22.2, 25.4) 20.1 (18.7, 21.6) 13.8 (12.6, 15.1)
Sex
Male 2,061 (49.1) 38.3 (35.8, 40.8) 23.9 (21.6, 26.2) 21.3 (19.2, 23.4) 16.5 (14.6, 18.4)
Female 2,137 (50.9) 46.0 (43.5, 48.5) 23.6 (21.5, 25.8) 19.0 (17.0, 21.0) 11.4 (9.7, 13.0)
Age (years)
Z65 922 (22.0) 48.7 (45.2, 52.3) 23.4 (20.4, 26.5) 17.2 (14.5, 19.8) 10.7 (8.6, 12.7)
45–64 1,845 (43.9) 44.1 (41.4, 46.7) 20.7 (18.7, 22.8) 21.3 (19.1, 23.4) 13.9 (12.1, 15.8)
2544 1,173 (27.9) 38.7 (35.4, 42.0) 25.0 (22.0, 28.0) 21.1 (18.4, 23.8) 15.2 (12.8, 17.6)
1824 258 (6.1) 37.5 (31.2, 43.8) 29.3 (23.3, 35.4) 18.5 (13.5, 23.5) 14.7 (9.9, 19.5)
Race/ethnicity
White, NH 3,169 (75.5) 41.6 (39.6, 43.6) 23.9 (22.2, 25.7) 21.4 (19.7, 23.0) 13.1 (11.7, 14.4)
Black, NH 395 (9.4) 40.3 (34.7, 45.8) 24.3 (19.4, 29.2) 20.5 (15.8, 25.2) 14.9 (10.7, 19.1)
Other, NH 228 (5.4) 49.1 (40.9, 57.4) 21.3 (14.3, 28.2) 14.7 (9.5, 19.9) 14.9 (9.4, 20.5)
Hispanic 406 (9.7) 43.5 (38.0, 49.1) 23.7 (18.8, 28.7) 16.8 (12.7, 20.9) 16.0 (11.8, 20.1)
Education
College degree 1,386 (33.0) 45.2 (42.1, 48.4) 24.8 (22.1, 27.6) 18.5 (16.1, 20.9) 11.4 (9.5, 13.4)
Some college 1,296 (30.9) 44.8 (42.6, 48.0) 19.4 (16.8, 22.0) 19.4 (16.9, 21.8) 16.4 (14.0, 18.8)
High school 1,228 (29.2) 40.4 (37.2, 43.6) 25.3 (22.4, 28.1) 21.9 (19.3, 24.6) 12.4 (10.3, 14.4)
oHigh school 288 (6.9) 33.7 (27.7, 39.7) 28.0 (22.0, 34.0) 21.2 (16.0, 26.5) 17.0 (12.0, 22.0)
Annual household income
Z$60,000 2,065 (49.2) 44.5 (41.9, 47.0) 24.6 (22.3, 26.8) 18.3 (16.4, 20.2) 12.6 (10.9, 14.3)
$40,000–$59,999 757 (18.0) 45.3 (41.1, 49.6) 22.1 (18.6, 25.6) 20.5 (17.1, 23.9) 12.1 (9.3, 14.9)
$25,000–$39,999 700 (16.7) 42.6 (38.2, 47.0) 23.2 (19.5, 27.0) 20.1 (16.6, 23.6) 14.1 (11.0, 17.1)
$15,000–$24,999 305 (7.3) 41.4 (35.0, 47.9) 23.6 (17.9, 29.4) 24.6 (19.0, 30.3) 10.3 (6.9, 13.6)
o$15,000 371 (8.8) 24.6 (19.7, 29.5) 23.4 (18.0, 28.8) 24.8 (19.2, 30.4) 27.2 (21.5, 32.9)
U.S. Census regionb
Northeast 747 (17.8) 44.3 (40.1, 48.4) 22.5 (18.8, 26.1) 19.7 (16.4, 23.1) 13.5 (10.7, 16.4)
Midwest 1,058 (25.2) 39.3 (35.8, 42.8) 25.3 (22.2, 28.5) 21.1 (18.2, 24.0) 14.3 (11.7, 16.8)
South 1,494 (35.6) 41.9 (39.0, 44.9) 22.0 (19.5, 24.5) 21.2 (18.8, 23.7) 14.9 (12.6, 17.1)
West 899 (21.4) 44.0 (40.0, 47.9) 26.2 (22.6, 29.8) 17.7 (14.8, 20.6) 12.1 (9.7, 14.5)
Cigarette smokingc
Never smoker 2,241 (55.2) 47.6 (45.1, 50.1) 24.2 (22.1, 26.4) 17.1, (15.2, 18.9) 11.1 (9.5, 12.7)
Former smoker 1,233 (30.4) 44.0 (40.8, 47.2) 22.3 (19.6, 25.0) 19.5 (17.0, 22.0) 14.1 (11.8, 16.4)
Current smoker 582 (14.4) 20.9 (16.8, 25.1) 25.5 (21.2, 29.9) 32.6 (28.0, 37.1) 21.0 (17.3, 24.6)
(continued on next page)
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increase the risk of adverse drug events.11–13 Fortunately,
approximately seven in ten cigarette smokers want to
quit.14 Although pharmacies can serve as a conduit for
patients to obtain evidence-based cessation support and
U.S. Food and Drug Administration–approved medica-
tions, the concurrent sale and advertisement of tobacco
products might counteract these resources by triggering
cravings, stimulating impulse purchases,15 and hindering
smokers’ quit attempts.
To reduce pharmacy tobacco sales, states and com-
munities can implement policies prohibiting tobacco
product sales in this environment. As of January 1,
2016, a total of 134 municipalities in California and
Massachusetts had enacted tobacco-free pharmacy laws.5
Implementation of comprehensive tobacco sales prohib-
itions, including cigarettes and other tobacco products,
could help reduce access to tobacco products and
exposure to tobacco product advertising, as well as
denormalize tobacco use. Initiatives to discontinue
tobacco sales could also positively reinforce pharmacy
stores’ commitment to health care. In addition, by
eliminating concurrent tobacco product sales, pharma-
cies may help bring public awareness to the health
consequences of smoking, and provide enhanced clinical
management of tobacco-related diseases.16,17 Moreover,
preliminary evaluation findings suggest such policies do
not adversely affect business. For example, in 2014, CVS
Caremark rebranded as CVS Health, and became the first
national retail pharmacy chain to cease tobacco product
sales. Following policy implementation, CVS reported
increased year-over-year net revenues, with positive
gains in pharmacy services.18
Limitations
This study is subject to at least three limitations. First,
Summer Styles is an Internet-based survey and may have
limited generalizability compared with traditional
population-based surveys.19 Second, data were self-
reported, which could result in misreporting of measures
such as tobacco use. Third, limited sample size prevented
analysis of more nuanced tobacco use categories, includ-
ing polytobacco use.
Conclusions
A majority of U.S. adults favor prohibiting tobacco sales
in retail pharmacy stores. Eliminating tobacco product
sales in these settings may reinforce pharmacy stores’
efforts to promote wellness, and further cultivate social
climates that reduce the desirability, acceptability, and
accessibility of tobacco. Prohibiting tobacco sales in
pharmacies, along with the implementation of proven
population-level tobacco control interventions, could
help reduce tobacco-related death and disease.
The findings and conclusions in this report are those of the
authors and do not necessarily represent the official position of
the Centers for Disease Control and Prevention.
Table 1. Favorability Toward Prohibiting Tobacco Product Sales in Retail Pharmacy Stores Among U.S. Adults, 2014a
(continued)
% (95% CI)
Characteristic n (%) Strongly favor Somewhat favor Somewhat oppose Strongly oppose
Non-cigarette tobacco productsd
Never user 2,263 (54.4) 48.9 (46.4, 51.3) 22.6 (20.5, 24.7) 16.9 (15.0, 18.7) 11.7 (10.0, 13.3)
Former user 1,473 (35.4) 37.2 (34.3, 40.1) 26.0 (23.3, 28.7) 21.8 (19.4, 24.3) 14.9 (12.9, 17.0)
Current user 421 (10.1) 23.9 (18.8, 29.0) 23.9 (18.8, 29.0) 30.2 (24.9, 35.4) 22.0 (17.4, 26.6)
aRespondents were asked: “Do you favor or oppose banning the sale of all tobacco products in retail pharmacy stores?” Responses were: “strongly
favor,” “somewhat favor,” “somewhat oppose,” and “strongly oppose.”
bNortheast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont.Midwest: Illinois,
Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South: Alabama, Arkansas,
Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee,
Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah,
Washington, and Wyoming.
cCurrent cigarette smokers are defined as respondents who smoked Z100 cigarettes in their lifetime and reported smoking “everyday” or “some
days” at the time of the survey. Former cigarette smokers are defined as respondents who smokedZ100 cigarettes in their lifetime and reported
smoking “not at all” at the time of the survey. Never cigarette smokers are defined as respondents who reported “no” to smokingZ100 cigarettes in
their lifetime.
dRespondents were asked about the ever or current (past 30-day) use of the following non-cigarette tobacco products: cigars or big cigars; cigarillos;
little cigars; chewing tobacco, snuff or dip; electronic cigarettes or e-cigarettes; electronic hookahs, hookah pens, or vape pens; some other electronic
vapor product such as electronic cigars or electronic pipes; water pipes; roll-your-own cigarettes; flavored cigars; snus; dissolvable tobacco products.
NH, non-Hispanic.
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Table 2. Adjusted Prevalence Ratios of Favorability Toward Prohibiting Tobacco Product Sales in Retail Pharmacy Stores
Among U.S. Adults, 2014a
Characteristic n (%) % (95% CI) APR (95% CI)b
Overall 4,198 66.1 (64.3, 67.8)
Sex
Male 2,061 (49.1) 62.2 (59.7, 64.7) ref
Female 2,137 (50.9) 69.7 (67.3, 72.0) 1.08 (1.03, 1.14)
Age (years)
Z65 922 (22.0) 72.2 (69.0, 75.3) ref
45–64 1,845 (43.9) 64.8 (62.3, 67.3) 0.94 (0.88, 0.99)
25–44 1,173 (27.9) 63.7 (60.5, 66.9) 0.91 (0.86, 0.98)
18–24 258 (6.1) 66.8 (60.7, 73.0) 0.95 (0.86, 1.06)
Race/ethnicity
White, NH 3,169 (75.5) 65.5 (63.6, 67.5) ref
Black, NH 395 (9.4) 64.6 (59.1, 70.2) 1.02 (0.93, 1.12)
Other, NH 228 (5.4) 70.4 (63.3, 77.5) 1.09 (0.99, 1.21)
Hispanic 406 (9.7) 67.3 (62.0, 72.5) 1.07 (0.99, 1.17)
Education
College degree 1,386 (33.0) 70.1 (67.2, 72.9) ref
Some college 1,296 (30.9) 64.2 (61.2, 67.3) 0.95 (0.89, 1.02)
High school 1,228 (29.2) 65.7 (62.6, 68.7) 0.99 (0.93, 1.05)
oHigh school 288 (6.9) 61.7 (55.4, 68.1) 1.00 (0.89, 1.12)
Annual household income
Z$60,000 2,065 (49.2) 69.0 (66.7, 71.4) ref
$40,000–$59,999 757 (18.0) 67.4 (63.5, 71.4) 1.00 (0.94, 1.07)
$25,000–$39,999 700 (16.7) 65.8 (61.7, 70.0) 1.00 (0.93, 1.07)
$15,000–$24,999 305 (7.3) 65.1 (59.0, 71.2) 1.01 (0.92, 1.12)
o$15,000 371 (8.8) 48.0 (41.8, 54.2) 0.82 (0.71, 0.94)
U.S. Census regionc
Northeast 747 (17.8) 66.7 (62.8, 70.7) ref
Midwest 1,058 (25.2) 64.6 (61.2, 68.1) 0.99 (0.92, 1.07)
South 1,494 (35.6) 63.9 (61.0, 66.8) 0.96 (0.89, 1.04)
West 899 (21.4) 70.2 (66.7, 73.7) 1.02 (0.94, 1.10)
Cigarette smokingd
Never smoker 2,241 (55.2) 71.8 (69.6, 74.1) ref
Former smoker 1,233 (30.4) 66.3 (63.3, 69.4) 0.96 (0.90, 1.02)
Current smoker 582 (14.4) 46.5 (41.5, 51.4) 0.73 (0.65, 0.82)
Non-cigarette tobacco productse
Never user 2,263 (54.4) 71.4 (69.2, 73.7) ref
(continued on next page)
Wang et al / Am J Prev Med 2016;51(6):1038–10431042
www.ajpmonline.org
No financial disclosures were reported by the authors of
this paper.
References
1. DHHS. The Health Consequences of Smoking—50 Years of Progress: a
Report of the Surgeon General. Atlanta, GA: DHHS, Center for Disease
Control and Prevention; 2014. www.surgeongeneral.gov/library/
reports/50-years-of-progress/full-report.pdf Accessed January 6, 2016.
2. Kotecki JE, Elanjian SI, Torabi MR, Clark JK. Pharmacists’ concerns
and suggestions related to the sale of tobacco and alcohol in
pharmacies. J Community Health. 1998;23(5):359–370. http://dx.doi.
org/10.1023/A:1018797805959.
3. Hudmon KS, Fenlon CM, Corelli RL, Prokhorov AV, Schroeder SA.
Tobacco sales in pharmacies: time to quit. Tob Control. 2006;15(1):
35–38. http://dx.doi.org/10.1136/tc.2005.012278.
4. Smith DM, Hyland AJ, Rivard C, et al. Tobacco sales in pharmacies: a
survey of attitudes, knowledge and beliefs of pharmacists employed in
student experiential and other worksites in Western New York. BMC
Res Notes. 2012;5:413. http://dx.doi.org/10.1186/1756-0500-5-413.
5. American Pharmacists Association Policy Manual. American Pharmacists
Association website. www.pharmacist.com/policy-manual. Accessed Febru-
ary 1, 2016.
6. Patwardhan P, McMillen R, Winickoff JP. Consumer perceptions of
the sale of tobacco products in pharmacies and grocery stores among
U.S. adults. BMC Res Notes. 2013;6:261. http://dx.doi.org/10.1186/
1756-0500-6-261.
7. Kroon A, Corelli R, Roth A, Hudmon K. Public perceptions of the ban on
tobacco sales in San Francisco pharmacies. Tob Control. 2013;22:369–371.
http://dx.doi.org/10.1136/tobaccocontrol-2012-050602.
8. American Nonsmokers’ Rights Foundation. Municipalities with
tobacco-free pharmacy laws enacted as of January 1, 2016. http://
no-smoke.org/pdf/pharmacies.pdf. Accessed January 16, 2016.
9. Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA. Toking,
vaping, and eating for health or fun: marijuana use patterns in adults,
U.S., 2014. Am J Prev Med. 2016;50(1):1–8. http://dx.doi.org/10.1016/j.
amepre.2015.05.027.
10. San Francisco Tobacco-Free Project. San Francisco tobacco control
laws. Revised November 2015. http://2gahjr48mok145j3z438sknv.
wpengine.netdna-cdn.com/wp-content/uploads/San-Francisco-Tobac
co-Control-Laws-November-2015-1.pdf. Accessed February 2, 2016.
11. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking
impairs the therapeutic response to oral corticosteroids in chronic
asthma. Am J Respir Crit Care Med. 2003;168(11):1308–1311. http:
//dx.doi.org/10.1164/rccm.200304-503OC.
12. Tanis BC, van den Bosch MAAJ, Kemmeren JM, et al. Oral contra-
ceptives and the risk of myocardial infarction. N Engl J Med.
2001;345:1787–1793. http://dx.doi.org/10.1056/NEJMoa003216.
13. Krumme AA, Choudhry NK, Shrank WH, et al. Cigarette purchases
at pharmacies by patients at high risk of smoking-related illnesses.
JAMA Intern Med. 2014;174(12):2031–2032. http://dx.doi.org/
10.1001/jamainternmed.2014.5307.
14. Malarcher A, Dube S, Shaw L, Babb S, Kaufmann R. Quitting smoking
among adults—United States, 2001–2010. MMWR Morb Mortal Wkly
Rep. 2011;60(44):1513–1519.
15. Wakefield M, Germain D, Henriksen L. The effect of retail cigarette
pack displays on impulse purchase. Addiction. 2008;103(2):322–328.
http://dx.doi.org/10.1111/j.1360-0443.2007.02062.x.
16. McDaniel PA, Malone RE. Why California retailers stop selling
tobacco products, and what their customers and employees think
about it when they do: case studies. BMC Public Health. 2011;11:848.
http://dx.doi.org/10.1186/1471-2458-11-848.
17. BrennanTA, Schroeder SA. Ending sales of tobacco products in pharmacies.
JAMA. 2014;311(11):1105–1106. http://dx.doi.org/10.1001/jama.2014.686.
18. CVS Health reports third quarter results. CVS Health website. www.
cvshealth.com/content/cvs-health-reports-third-quarter-results. Pub-
lished November 2014. Accessed January 22, 2016.
19. Yeager DS, Krosnick JA, Chang L, et al. Comparing the accuracy of
RDD telephone surveys and internet surveys conducted with proba-
bility and non-probability samples. Public Opin Q. 2011;75(4):709–
747. http://dx.doi.org/10.1093/poq/nfr020.
Table 2. Adjusted Prevalence Ratios of Favorability Toward Prohibiting Tobacco Product Sales in Retail Pharmacy Stores
Among U.S. Adults, 2014a (continued)
Characteristic n (%) % (95% CI) APR (95% CI)b
Former user 1,473 (35.4) 63.2 (60.4, 66.1) 0.93 (0.87, 0.99)
Current user 421 (10.1) 47.8 (42.0, 53.6) 0.80 (0.70, 0.92)
Note: Boldface indicates statistical significance (po0.05).
aFavorability defined as a report of “strongly favor” or “somewhat favor” to the question, “Do you favor or oppose banning the sale of all tobacco
products in retail pharmacy stores?”
bAdjusted prevalence ratios were obtained using Poisson Regression model adjusted for all covariates listed in the table.
cNortheast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont.Midwest: Illinois,
Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South: Alabama, Arkansas,
Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee,
Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah,
Washington, and Wyoming.
dCurrent cigarette smokers are defined as respondents who smoked Z100 cigarettes in their lifetime and reported smoking “everyday” or “some
days” at the time of the survey. Former cigarette smokers are defined as respondents who smokedZ100 cigarettes in their lifetime and reported
smoking “not at all” at the time of the survey. Never cigarette smokers are defined as respondents who reported “no” to smokingZ100 cigarettes in
their lifetime.
eRespondents were asked about the ever or current (past 30-day) use of the following non-cigarette tobacco products: cigars or big cigars; cigarillos;
little cigars; chewing tobacco, snuff or dip; electronic cigarettes or e-cigarettes; electronic hookahs, hookah pens, or vape pens; some other electronic
vapor product such as electronic cigars or electronic pipes; water pipes; roll-your-own cigarettes; flavored cigars; snus; dissolvable tobacco products.
APR, adjusted prevalence ratio; NH, non-Hispanic.
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